‘Medications’ at Psychology, Philosophy and Real Life, Page 6

The following articles are related to ‘Medications’ at Psychology, Philosophy and Real Life.

CBT as Effective for Sleep Problems as Medications Like Ambien

By Dr Greg Mulhauser, Managing Editor | 27 February 2006

No, that’s not to say that CBT will put you to sleep! Rather, an article carried on the APA’s PsycPort highlights studies indicating that cognitive behavioural therapy can improve sleep about as well as drugs can. According to the article, not only can talk therapy such as CBT help with sleeping problems, but its effects continue for many months — unlike the effects of drugs, where effectiveness is not known to continue after discontinuing the medication.

Read More »

Pleasure-Blocker Accomplia Shows Promise as Weight-Loss Drug

By Dr Greg Mulhauser, Managing Editor | 16 February 2006

A 2-year longitudinal study shows that men and women taking the experimental weight-loss drug rimonabant lost weight and kept it off. However, specialists warn that medication use should be minimized when lifestyle changes can achieve the same purpose.

Read More »

Mixed Messages on ADHD Drugs Side Effects

By Dr Greg Mulhauser, Managing Editor | 15 February 2006

Last week, an FDA advisory committee voted to recommend adding ‘black box’ safety warnings to ADHD drugs. This week, the director of the FDA’s division of psychiatry products says it would be unusual for the agency to issue a ‘black box’ warning based on such thin evidence. A second FDA committee, which focuses on pediatrics, will consider the drugs’ safety next month.

Read More »

Black Box Warnings for Ritalin and Other ADHD Drugs

By Dr Greg Mulhauser, Managing Editor | 10 February 2006

It’s official: an FDA science advisory committee has voted to recommend the most serious type of ‘black box’ warning labels for Ritalin and other stimulants used in the treatment of attention deficit hyperactivity disorder.

Read More »

FDA to Issue Public Health Advisory on Antidepressants During Pregnancy

By Dr Greg Mulhauser, Managing Editor | 9 February 2006

According to Dr. Sandra Kweder, deputy director of the FDA’s Office of New Drugs, the agency will issue a public health advisory within days in response to an article in the New England Journal of Medicine that links use of drugs like Paxil, Prozac, and Zoloft late in pregnancy with a condition that can endanger infants’ lives.

Read More »

Page 6 of 11« First...4567810...Last »